In vivo delivery of RNAi with lipid-based nanoparticles
Abstract
RNA interference (RNAi) technology represents a fundamentally new category of treatments for human disease by addressing targets that are traditionally considered undruggable with existing medicines. The major challenge for RNAi-based therapy is the delivery system that meets human therapeutic needs. Therefore, engineering vectors with good delivery efficiency and safety profile is an intense area of research. Lipid-based nanoparticles for RNAi have yielded successful advances in vivo and to an extent in clinical trials. In this review, we discuss the barriers in developing lipid-based nanoparticles for in vivo RNAi and different strategies to overcome them. Rational designs that address safety concerns and ensure effective delivery will aid the translation of engineered lipid-based nanoparticles toward the clinic in the foreseeable future.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LNPs encapsulate and protect RNAs from degradation during circulation and deliver RNA payloads to target organs following systemic administration.
“The exceptional properties of LNPs for RNA delivery include, but are not limited to, the encapsulation and protection of RNAs from degradation during circulation, as well as the delivery of RNA payloads to the target organ following systemic administration.[18, 54, 61]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [61]
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,771 · see citing works
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256 · see citing works
The nuclear RNase III Drosha initiates microRNA processing
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., et al. (2003) · Nature · doi:10.1038/nature01957 · Cited by 5,094 · see citing works
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954 · see citing works
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 4,896 · see citing works
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,295 · see citing works
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947 · see citing works
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637 · see citing works
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444 · see citing works
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170 · see citing works
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115 · see citing works
Mechanisms of gene silencing by double-stranded RNA
Meister, G., & Tuschl, T. (2004) · Nature · doi:10.1038/nature02873 · Cited by 2,539 · see citing works
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D. B., Tolcher, A. W., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,508 · see citing works
MicroRNA maturation: stepwise processing and subcellular localization
Lee, Y., Jeon, K., Lee, J., Kim, S., & Kim, V. N. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf476 · Cited by 2,468 · see citing works
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438 · see citing works
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370 · see citing works
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · see citing works
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Kota, J., Chivukula, R. R., O’Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H., Chang, T.-C., Vivekanandan, P., Torbenson, M. S., Clark, K. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.021 · Cited by 1,711 · see citing works
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677 · see citing works
Grishok, A., Pasquinelli, A. E., Conte, D., Li, N., Parrish, S., Ha, I., Baillie, D. L., Fire, A., Ruvkun, G., & Mello, C. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00431-7 · Cited by 1,600 · see citing works
Pharmacokinetics and Biodistribution of Nanoparticles
Li, S., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,570 · see citing works
Self-citationShort hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cellsPreprint
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,554 · see citing works
Activation of the interferon system by short-interfering RNAs
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., & Williams, B. R. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1038 · Cited by 1,401 · see citing works
Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis
Akinc, A., Thomas, M., Klibanov, A. M., & Langer, R. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.696 · Cited by 1,339 · see citing works
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261 · see citing works
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250 · see citing works
Hornung, V., Guenthner‐Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A. M., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,233 · see citing works
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M. S., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S., Nguyen, D. N., Fuller, J. E., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,228 · see citing works
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,228 · see citing works
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H., Maraganore, J. M., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,202 · see citing works
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K. S., Jensen, K., Breen, W., Hartsough, K. C., Machemer, L., Radka, S. F., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168 · see citing works
Distinct endocytic pathways regulate TGF-β receptor signalling and turnover
Guglielmo, G. M. D., Roy, C. L., Goodfellow, A. F., & Wrana, J. L. (2003) · Nature Cell Biology · doi:10.1038/ncb975 · Cited by 1,152 · see citing works
Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,
Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,136 · see citing works
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129 · see citing works
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes
Sonawane, N. D., Szoka, F. C., & Verkman, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308643200 · Cited by 1,083 · see citing works
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078 · see citing works
RNA interference in adult mice
McCaffrey, A. P., Meuse, L. A., Pham, T.-T. T., Conklin, D. S., Hannon, G. J., & Kay, M. A. (2002) · Nature · doi:10.1038/418038a · Cited by 1,060 · see citing works
Lipid-like materials for low-dose, in vivo gene silencing
Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969 · see citing works
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
Birmingham, A., Anderson, E. M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J., et al. (2006) · Nature Methods · doi:10.1038/nmeth854 · Cited by 920 · see citing works
Bartlett, D. W., Su, H. C., Hildebrandt, I. J., Weber, W., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 808 · see citing works
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J. M., Guo, J., Johnson, J. M., Lim, L. P., Karpilow, J. M., Nichols, K. E., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 790 · see citing works
siRNA vs. shRNA: Similarities and differences
Rao, D. D., Vorhies, J. S., Senzer, N. N., & Nemunaitis, J. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.004 · Cited by 658 · see citing works
Frank-Kamenetsky, M. D., Grefhorst, A., Anderson, N. N., Racie, T., Bramlage, B., Akinc, A., Butler, D., Charissé, K., Dorkin, J. R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 635 · see citing works
Second-generation shRNA libraries covering the mouse and human genomes
Silva, J. M., Li, M. Z., Chang, K. C. N., Ge, W., Golding, M. C., Rickles, R. J., Siolas, D., Hu, G., Paddison, P. J., Schlabach, M. R., et al. (2005) · Nature Genetics · doi:10.1038/ng1650 · Cited by 624 · see citing works
McBride, J. L., Boudreau, R. L., Harper, S. Q., Staber, P. D., Mas, A., Martins, I., Gilmore, B. L., Burstein, H., PELUSO, R. W., Polisky, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801775105 · Cited by 610 · see citing works
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
Hafez, I., Maurer, N., & Cullis, P. R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601 · see citing works
Bartlett, D. W. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj439 · Cited by 593 · see citing works
Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting
Li, S., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.016 · Cited by 562 · see citing works
Self-citationKingshott, P., Thissen, H. W., & Griesser, H. J. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00334-9 · Cited by 538 · see citing works
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 516 · see citing works
Self-citationThe role of complement in inflammation and phagocytosis
Frank, M. M., & Fries, L. F. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90009-i · Cited by 504 · see citing works
Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer
Li, S., & Huang, L. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.06.022 · Cited by 487 · see citing works
Self-citationEnhancing polyethylenimine's delivery of plasmid DNA into mammalian cells
Thomas, M., & Klibanov, A. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192581499 · Cited by 483 · see citing works
Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
Li, J., Chen, Y.-C., Tseng, Y. C., Mozumdar, S., & Huang, L. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.008 · Cited by 467 · see citing works
Self-citationLipid-based systemic delivery of siRNA
Tseng, Y.-C., Mozumdar, S., & Huang, L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.003 · Cited by 463 · see citing works
Self-citationKarikó, K., Bhuyan, P. K., Capodici, J., & Weissman, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6545 · Cited by 446 · see citing works
Kenworthy, A. K., Hristova, K. A., Needham, D., & McIntosh, T. J. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)80369-3 · Cited by 404 · see citing works
Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo
Bertrand, J., Pottier, M., Vekris, A., Opolon, P., Maksimenko, A., & Malvy, C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02013-2 · Cited by 400 · see citing works
Hatakeyama, H., Akita, H., Kogure, K., Oishi, M., Nagasaki, Y., Kihira, Y., Ueno, M., Kobayashi, H., Kikuchi, H., & Harashima, H. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302843 · Cited by 397 · see citing works
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382 · see citing works
Mori, A., Klibanov, A. L., Torchilin, V. P., & Huang, L. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80699-4 · Cited by 369 · see citing works
Self-citationRoser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 357 · see citing works
Chemical modification of siRNAs to improve serum stability without loss of efficacy
Choung, S., Kim, Y., Kim, S., Park, H.-O., & Choi, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.049 · Cited by 348 · see citing works
Walker, G. F., Fella, C., Pelisek, J., Fahrmeir, J., Boeckle, S., Ogris, M., & Wagner, E. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.006 · Cited by 322 · see citing works
Delivery of Molecular Medicine to Solid Tumors
Jain, R. K. (1996) · Science · doi:10.1126/science.271.5252.1079 · Cited by 312 · see citing works
Ishida, O., Maruyama, K., Sasaki, K., & Iwatsuru, M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00256-2 · Cited by 309 · see citing works
Stabilized plasmid-lipid particles: construction and characterization
Wheeler, J. J., Palmer, L., Ossanlou, M., MacLachlan, I., Graham, R. W., Zhang, Y. P., Hope, M. J., Scherrer, P., & Cullis, P. R. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300821 · Cited by 300 · see citing works
A status report on RNAi therapeutics
Vaishnaw, A. K., Gollob, J., Gamba‐Vitalo, C., Hutabarat, R. M., Sah, D. W. Y., Meyers, R. E., de Fougerolles, T., & Maraganore, J. M. (2010) · Silence · doi:10.1186/1758-907x-1-14 · Cited by 297 · see citing works
Lipid Polymorphism:The Molecular Basis of Nonbilayer Phases
Gruner, S. M., Cullis, P. R., Hope, M. J., & Tilcock, C. (1985) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.14.060185.001235 · Cited by 296 · see citing works
Judge, A. D., McClintock, K., Phelps, J. R., & MacLachlan, I. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.014 · Cited by 280 · see citing works
Roles of lipid polymorphism in intracellular delivery
Hafez, I. M., & Cullis, P. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00103-x · Cited by 267 · see citing works
Taulli, R., Bersani, F., Foglizzo, V., Linari, A., Vigna, E., Ladanyi, M., Tuschl, T., & Ponzetto, C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38075 · Cited by 258 · see citing works
Biodistribution of phosphodiester and phosphorothioate siRNA
Braasch, D. A., Paroo, Z., Constantinescu, A., Ren, G., Öz, O. K., Mason, R. P., & Corey, D. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.074 · Cited by 251 · see citing works
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes
Woodle, M. C., Matthay, K. K., Newman, M. S., Hidayat, J., Collins, L. R., Redemann, C. T., Martin, F. J., & Papahadjopoulos, D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90194-q · Cited by 241 · see citing works
Steric Stabilization of Fusogenic Liposomes by a Low-pH Sensitive PEG−Diortho Ester−Lipid Conjugate
Guo, X. D., & Szoka, F. C. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000110v · Cited by 233 · see citing works
Lipid membranes with grafted polymers: physicochemical aspects
Marsh, D., Bartucci, R., & Sportelli, L. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00197-4 · Cited by 232 · see citing works
Hong, R. L., Huang, C. J., Tseng, Y., Pang, V. F., Chen, S.-T., Liu, J. J., & Chang, F. (1999) · PubMed · Cited by 227 · see citing works
Holland, J. W., Hui, C., Cullis, P. R., & Madden, T. D. (1996) · Biochemistry · doi:10.1021/bi952000v · Cited by 223 · see citing works
Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
Robbins, M., Judge, A. D., Ambegia, E., Choi, C., Yaworski, E., Palmer, L., McClintock, K., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.131 · Cited by 222 · see citing works
A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery
Lu, J. J.-Q., Langer, R., & Chen, J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900023v · Cited by 219 · see citing works
van de Water, F. M., Boerman, O. C., Wouterse, A. C., Peters, J. G. P., Rüssel, F. G. M., & Masereeuw, R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009555 · Cited by 217 · see citing works
Progress and prospects: nuclear import of nonviral vectors
Lam, A. P., & Dean, D. A. (2010) · Gene Therapy · doi:10.1038/gt.2010.31 · Cited by 211 · see citing works
Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211 · see citing works
Liposome-mediated DNA vaccination: the effect of vesicle composition
Perrie, Y., Frederik, P. M., & Gregoriadis, G. C. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00432-1 · Cited by 210 · see citing works
Cationic liposomal lipids: From gene carriers to cell signaling
Lonez, C., Vandenbranden, M., & Ruysschaert, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.03.002 · Cited by 208 · see citing works
Zalipsky, S., Qazen, M. M., Walker, J. A., Mullah, N. N., Quinn, Y. P., & Huang, S. K. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990031n · Cited by 198 · see citing works
Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
Li, S., Chono, S., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.51 · Cited by 195 · see citing works
Self-citationImmunostimulation of dendritic cells by cationic liposomes
Vangasseri, D. P., Cui, Z., Chen, W., Hokey, D. A., Falo, L. D., & Huang, L. (2006) · Molecular Membrane Biology · doi:10.1080/09687860600790537 · Cited by 183 · see citing works
Self-citationYan, W., Chen, W., & Huang, L. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.04.009 · Cited by 178 · see citing works
Self-citationBreaking the Bonds: Non-viral Vectors Become Chemically Dynamic
Wolff, J. A., & Rozema, D. B. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300326 · Cited by 163 · see citing works
Omidi, Y., Hollins, A. J., Benboubetra, M., Drayton, R. M., Benter, I. F., & Akhtar, S. (2003) · Journal of drug targeting · doi:10.1080/10611860310001636908 · Cited by 152 · see citing works
Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs
Bragonzi, A., Dina, G., Villa, A., Calori, G., Biffi, A., Bordignon, C., Assael, B. M., & Conese, M. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301282 · Cited by 151 · see citing works
MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity
Turner, J. J., Jones, S. W., Moschos, S. A., Lindsay, M. A., & Gait, M. J. (2006) · Molecular BioSystems · doi:10.1039/b611612d · Cited by 146 · see citing works
siRNA applications in nanomedicine
Tokatlian, T., & Segura, T. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.81 · Cited by 138 · see citing works
Parr, M. J., Masin, D., Cullis, P. R., & Bally, M. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36521-8 · Cited by 126 · see citing works
Characteristics and biodistribution of cationic liposomes and their DNA complexes
Ishiwata, H., Suzuki, N., Ando, S., Kikuchi, H., & Kitagawa, T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00293-5 · Cited by 117 · see citing works
Hollins, A. J., Omidi, Y., Benter, I. F., & Akhtar, S. (2007) · Journal of drug targeting · doi:10.1080/10611860601151860 · Cited by 116 · see citing works
Preall, J. B., & Sontheimer, E. J. (2005) · Cell · doi:10.1016/j.cell.2005.11.006 · Cited by 114 · see citing works
Bedu-Addo, F. K., Tang, P. S., Xu, Y., & Huang, L. (1996) · Pharmaceutical Research · doi:10.1023/a:1016091314940 · Cited by 105 · see citing works
Self-citationStabilization of bilayer structure for unsaturated phosphatidylethanolamines by detergents
Madden, T. D., & Cullis, P. R. (1982) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(82)90061-x · Cited by 103 · see citing works
Immunostimulation Mechanism of LPD Nanoparticle as a Vaccine Carrier
Cui, Z., Han, S., Vangasseri, D. P., & Huang, L. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049907k · Cited by 99 · see citing works
Self-citationZhang, J. X. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.09.003 · Cited by 95 · see citing works
Holland, J. W., Cullis, P. R., & Madden, T. D. (1996) · Biochemistry · doi:10.1021/bi951999j · Cited by 86 · see citing works
Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production
Tagami, T., Nakamura, K., Shimizu, T., Ishida, T., & Kiwada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.006 · Cited by 81 · see citing works
Monck, M. A., Mori, A., Lee, D., Tam, P., Wheeler, J. J., Cullis, P. R., & Scherrer, P. (2000) · Journal of drug targeting · doi:10.3109/10611860009102218 · Cited by 78 · see citing works
CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes
Tagami, T., Nakamura, K., Shimizu, T., Yamazaki, N., Ishida, T., & Kiwada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.017 · Cited by 77 · see citing works
[3] Stabilized plasmid-lipid particles: A systemic gene therapy vector
Fenske, D. B., MacLachlan, I., & Cullis, P. R. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)46048-x · Cited by 71 · see citing works
Baker, M. (2010) · Nature · doi:10.1038/4641225a · Cited by 62 · see citing works
Defective antigen processing correlates with a low level of intracellular glutathione
Short, S., Merkel, B. J., Caffrey, R., & McCoy, K. L. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261229 · Cited by 57 · see citing works
Shimada, K., Matsuo, S., Sadzuka, Y., Miyagishima, A., Nozawa, Y., Hirota, S., & Sonobe, T. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00466-x · Cited by 54 · see citing works
The effect of surface charges of liposomes in immunopotentiation
Latif, N. A., & Bachhawat, B. K. (1984) · Bioscience Reports · doi:10.1007/bf01120305 · Cited by 38 · see citing works
Lipid-Protamine-DNA-Mediated Antigen Delivery
Vangasseri, D., Han, S., & Huang, L. (2005) · Current Drug Delivery · doi:10.2174/156720105774370168 · Cited by 31 · see citing works
Self-citationSynthetic vs. Natural/Biodegradable Polymers for Delivery of shRNA-Based Cancer Therapies
Vorhies, J. S., & Nemunaitis, J. J. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-429-2_2 · Cited by 26 · see citing works
Mandel, R., Ryser, H. J. ‐., Niaki, B., Ghani, F., & Shen, W. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041490109 · Cited by 9 · see citing works
Decherf, S., Hassani, Z., & DEMENEIX, B. A. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-237-3_21 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800 · see citing works
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B. C., Huang, P., & Chen, X. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,804 · see citing works
Current Strategies for Brain Drug Delivery
Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954 · see citing works
“Moreover, nanoparticles, because of their nano size (< 200 nm), could penetrate into ‘leaky’ tumor tissue to facilitate drug delivery according to the enhanced permeability and retention (EPR) effect [32].”
BackgroundCancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 946 · see citing works
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 863 · see citing works
Feng, T., Ai, X., An, G., Yang, P., & Zhao, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b00043 · Cited by 652 · see citing works
Targeting long non-coding RNA to therapeutically upregulate gene expression
Wahlestedt, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4018 · Cited by 524 · see citing works
Yuan, H., Fales, A. M., & Vo‐Dinh, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304180y · Cited by 525 · see citing works
Chen, D. L., Love, K. T., Chen, Y., Eltoukhy, A. A., Kastrup, C. J., Sahay, G., Jeon, A., Dong, Y., Whitehead, K. A., & Anderson, D. G. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301621z · Cited by 422 · see citing works
The role of nanotechnology in the treatment of viral infections
Singh, L., Kruger, H. G., Maguire, G. E. M., Govender, T., & Parboosing, R. (2017) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117713593 · Cited by 364 · see citing works
In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles?
Zhang, Y., Satterlee, A., & Huang, L. (2012) · Molecular Therapy · doi:10.1038/mt.2012.79 · Cited by 353 · see citing works
Self-citationYan, S., Ren, B., & Shen, J. (2020) · Insect Science · doi:10.1111/1744-7917.12822 · Cited by 307 · see citing works
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2019) · Advanced Materials · doi:10.1002/adma.201901081 · Cited by 257 · see citing works
Hypoxia‐Targeted siRNA Delivery
Perche, F., Biswas, S., Wang, T., Zhu, L., & Torchilin, V. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308368 · Cited by 236 · see citing works
Advances in lipid nanoparticles for siRNA delivery
Tam, Y., Chen, S., & Cullis, P. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5030498 · Cited by 229 · see citing works
Zhang, Y., Zhao, Y., Shen, J., Sun, X., Liu, Y., Liu, H., Wang, Y., & Wang, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04296 · Cited by 222 · see citing works
Self-citationDu, J., Mao, C., Yuan, Y., Yang, X., & Wang, J. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.002 · Cited by 204 · see citing works
Viger-Gravel, J., Schantz, A., Pinon, A. C., Rossini, A. J., Schantz, S., & Emsley, L. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b10795 · Cited by 202 · see citing works
Malek, E., Jagannathan, S., & Driscoll, J. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2469 · Cited by 194 · see citing works
Lipid Nanoparticles for Gene Delivery
Zhao, Y. D., & Huang, L. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00002-x · Cited by 182 · see citing works
Self-citationLee, M. Y., Yang, J., Jung, H. S., Beack, S., Choi, J. E., Hur, W., Koo, H., Kim, K., Yoon, S. K., & Hahn, S. K. (2012) · ACS Nano · doi:10.1021/nn302538y · Cited by 174 · see citing works
Piktel, E., Niemirowicz, K., Wątek, M., Wollny, T., Deptuła, P., & Bucki, R. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0193-x · Cited by 171 · see citing works
Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer
Daige, C. L., Wiggins, J. F., Priddy, L., Nelligan-Davis, T., Zhao, J. Y., & Brown, D. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0209 · Cited by 168 · see citing works
Nanoparticles containing insoluble drug for cancer therapy
Guo, S., & Huang, L. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.10.002 · Cited by 159 · see citing works
Self-citationArtificial nanovesicles for dsRNA delivery in spray‐induced gene silencing for crop protection
Qiao, L., Sánchez, J. N., Hamby, R., Capriotti, L., Chen, A., Mezzetti, B., & Jin, H. (2023) · Plant Biotechnology Journal · doi:10.1111/pbi.14001 · Cited by 156 · see citing works
Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors
Calabrese, G., Luca, G. D., Nocito, G., Rizzo, M. G., Lombardo, S. P., Chisari, G., Forte, S., Sciuto, E. L., & Sabrina Conoci, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111783 · Cited by 147 · see citing works
Chen, W., Lecaros, R. L. G., Tseng, Y.-C., Huang, L., & Hsu, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.12.052 · Cited by 128 · see citing works
Self-citationMatrix metalloproteinase 2-responsive micelle for siRNA delivery
Wang, H., Yang, X., Sun, C., Mao, C., Zhu, Y., & Wang, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.050 · Cited by 123 · see citing works
A Highly Efficient Synthetic Vector: Nonhydrodynamic Delivery of DNA to Hepatocyte Nucleiin Vivo
Hu, Y., Haynes, M. T., Wang, Y., Liu, F., & Huang, L. (2013) · ACS Nano · doi:10.1021/nn4012384 · Cited by 117 · see citing works
Self-citationBiotechnological approaches toward nanoparticle biofunctionalization
Avvakumova, S., Colombo, M., Tortora, P., & Prosperi, D. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.09.006 · Cited by 118 · see citing works
Core-Shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery
Gao, L.-Y., Liu, X.-Y., Chen, C.-J., Wang, J.-C., Feng, Q., Yu, M.-Z., Ma, X.-F., Pei, X.-W., Niu, Y.-J., Qiu, C., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.046 · Cited by 114 · see citing works
A basic insight into aptamer-drug conjugates (ApDCs)
Xuan, W., Peng, Y., Deng, Z., Peng, T., Kuai, H., Li, Y., He, J., Jin, C. Y., Liu, Y., Wang, R., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.021 · Cited by 111 · see citing works
Self-citationLong non-coding RNAs in genitourinary malignancies: a whole new world
Flippot, R., Beinse, G., Boilève, A., Vibert, J., & Malouf, G. G. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0195-1 · Cited by 107 · see citing works
Tzeng, S. Y., Hung, B. P., Grayson, W. L., & Green, J. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.036 · Cited by 99 · see citing works
Recent Advances in Nanoparticle-Based Cancer Treatment: A Review
Bajpai, S., Tiwary, S. K., Sonker, M., Joshi, A., Gupta, V., Kumar, Y., Shreyash, N., & Biswas, S. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c00779 · Cited by 99 · see citing works
Kang, M. R., Yang, G., Place, R. F., Charissé, K., Epstein-Barash, H., Manoharan, M., & Li, L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1871 · Cited by 99 · see citing works
Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
Liu, H., Zhang, Y., Xie, Y., Cai, Y., Baiyang, L., Li, W. J., Zeng, L.-Y., Li, Y., & Yu, R. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125286 · Cited by 94 · see citing works
Liu, Y., Hu, Y., & Huang, L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.022 · Cited by 93 · see citing works
Self-citationNanoparticle Delivery of Pooled siRNA for Effective Treatment of Non-Small Cell Lung Caner
Yang, Y., Hu, Y., Wang, Y., Li, J., Liu, F., & Huang, L. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300152v · Cited by 88 · see citing works
Self-citationXu, J., Kuang, Y., Lv, R., Yang, P., Li, C., Bi, H., Liu, B., Yang, D., Dai, Y., Gai, S., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.041 · Cited by 85 · see citing works
Liposome-targeted delivery for highly potent drugs
Bardania, H., Tarvirdipour, S., & Dorkoosh, F. A. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1290647 · Cited by 85 · see citing works
Fei, W., Zhang, Y., Han, S., Tao, J., Zheng, H., Wei, Y., Zhu, J., Li, F., & Wang, X. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.031 · Cited by 83 · see citing works
Boynuegri, T. A., Çıtak, C., Sirkecioglu, A. N., & Güner, F. S. (2012) · Polymer International · doi:10.1002/pi.4408 · Cited by 83 · see citing works
RNA delivery biomaterials for the treatment of genetic and rare diseases
Zhao, W., Hou, X., Vick, O. G., & Dong, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119291 · Cited by 82 · see citing works
Using Genome Sequence to Enable the Design of Medicines and Chemical Probes
Angelbello, A. J., Chen, J. L., Childs‐Disney, J. L., Zhang, P., Wang, Z.-F., & Disney, M. D. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00504 · Cited by 80 · see citing works
A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA
Luo, C., Miao, L., Zhao, Y. D., Musetti, S., Wang, Y., Shi, K., & Huang, L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.030 · Cited by 80 · see citing works
Self-citationOral delivery of small RNA and DNA
Forbes, D. C., & Peppas, N. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.037 · Cited by 76 · see citing works
Nanoparticle delivery of a peptide targeting EGFR signaling
Kim, S. K., & Huang, L. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.014 · Cited by 75 · see citing works
Self-citationPerrier, D. L., Rems, L., & Boukany, P. E. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.04.016 · Cited by 76 · see citing works
Hong, B. J., Chipre, A. J., & Nguyen, S. T. (2013) · Journal of the American Chemical Society · doi:10.1021/ja404491r · Cited by 73 · see citing works
Lipid nanoparticles for hepatic delivery of small interfering RNA
Yu, B., Hsu, S., Zhou, C., Wang, X., Terp, M. C., Wu, Y., Teng, L., Mao, Y., Wang, F., Xue, W., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.002 · Cited by 72 · see citing works
Song, Y. H., De, R., & Lee, K. T. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.103008 · Cited by 75 · see citing works
Structural modification of siRNA for efficient gene silencing
Lee, S. J., Son, S., Yhee, J. Y., Choi, K., Kwon, I. C., Kim, S. H., & Kim, K. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.09.002 · Cited by 71 · see citing works
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy
Xu, C., Liu, Y., Shen, S., Zhu, Y., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.068 · Cited by 71 · see citing works
Self-citationMcCaskill, J. L., Singhania, R., Burgess, M. L., Allavena, R., Wu, S. Y., Blumenthal, A., & McMillan, N. A. J. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.22 · Cited by 70 · see citing works
Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells
Landesman‐Milo, D., Goldsmith, M., Ben‐Arye, S. L., Witenberg, B., Brown, E., Leibovitch, S., Azriel, S., Tabak, S., Morad, V., & Peer, D. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.024 · Cited by 68 · see citing works
Electroporation of Intracellular Liposomes Using Nanosecond Electric Pulses—A Theoretical Study
Rems, L., Pucihar, G., & Damijan Miklavčič, A. (2013) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2013.2262177 · Cited by 68 · see citing works
Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran
Rizk, M., & Tüzmen, Ş. (2017) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s87945 · Cited by 68 · see citing works
Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy
Li, Q., Liu, X., Yan, C., Zhao, B., Zhao, Y., Yang, L., Shi, M., Yu, H., Li, X., & Luo, K. (2023) · Small · doi:10.1002/smll.202206211 · Cited by 66 · see citing works
Poustforoosh, A., Nematollahi, M. H., Hashemipour, H., & Pardakhty, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.015 · Cited by 61 · see citing works
Combinatorial Approach to Nanoarchitectonics for Nonviral Delivery of Nucleic Acids
Molla, M. R., & Levkin, P. A. (2015) · Advanced Materials · doi:10.1002/adma.201502888 · Cited by 62 · see citing works
Yuan, Y., Wang, F., Tang, W., Ding, Z., Wang, L., Liang, L., Zheng, Z., Zhang, H., & Liang, G. (2016) · ACS Nano · doi:10.1021/acsnano.6b03412 · Cited by 62 · see citing works
Sundar, S., & Prajapati, V. K. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800784630 · Cited by 61 · see citing works
Strategies to use microRNAs as therapeutic targets
Krützfeldt, J. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.07.004 · Cited by 62 · see citing works
Hypoxia‐Targeted siRNA Delivery
Perche, F., Biswas, S., Wang, T., Zhu, L., & Torchilin, V. P. (2014) · Angewandte Chemie · doi:10.1002/ange.201308368 · Cited by 60 · see citing works
Plasmonic nanoprobes for intracellular sensing and imaging
Yuan, H., Register, J. K., Wang, H., Fales, A. M., Liu, Y., & Vo‐Dinh, T. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-6975-1 · Cited by 59 · see citing works
Self-citationVideira, M., Arranja, A., Rafael, D. F. D. S., & Gaspar, R. S. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.11.018 · Cited by 58 · see citing works
Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA
Ge, X., Chen, L., Zhao, B., & Yuan, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598175 · Cited by 55 · see citing works
Hydroxychloroquine-conjugated gold nanoparticles for improved siRNA activity
Perche, F., Yi, Y., Hespel, L., Mi, P., Dirisala, A., Cabral, H., Miyata, K., & Kataoka, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.027 · Cited by 56 · see citing works
Nanomedicine for T‐Cell Mediated Immunotherapy
Li, F., Ouyang, J., Chen, Z., Zhou, Z., Essola, J. M., Ali, B., Wu, X., Zhu, M., Guo, W., & Liang, X. (2023) · Advanced Materials · doi:10.1002/adma.202301770 · Cited by 50 · see citing works
Rengaswamy, V., Zimmer, D., Süss, R., & Rössler, J. K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.063 · Cited by 50 · see citing works
Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments
Ghanbarian, H., Aghamiri, S., Eftekhary, M., Wagner, N., & Wagner, K. (2021) · Cells · doi:10.3390/cells10030591 · Cited by 48 · see citing works
Raghav, M., Gupta, V., Awasthi, R., Singh, A. K., & Kulkarni, G. T. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104756 · Cited by 51 · see citing works
Cellular Uptake and Antitumor Activity of DOX-hyd-PEG-FA Nanoparticles
Ye, W., Du, J., Zhang, B., Na, R., Song, Y., Mei, Q., Zhao, M., & Zhou, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097358 · Cited by 48 · see citing works
Toward personalized cancer nanomedicine – past, present, and future
Stegh, A. H. (2012) · Integrative Biology · doi:10.1039/c2ib20104f · Cited by 49 · see citing works
pH-Triggered Nanoparticle Mediated Delivery of siRNA to Liver Cells in Vitro and in Vivo
Kolli, S., Wong, S., Harbottle, R. P., Johnston, B. H., Thanou, M., & Miller, A. D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc3004099 · Cited by 46 · see citing works
Targeted si-RNA with liposomes and exosomes (extracellular vesicles): How to unlock the potential
Antimisiaris, S. G., Mourtas, S., & Παπαδιά, Κ. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.056 · Cited by 45 · see citing works
Tanaudommongkon, I., Tanaudommongkon, A., Prathipati, P., Nguyen, J. T., Keller, E. T., & Dong, X. (2020) · Biomedicines · doi:10.3390/biomedicines8080253 · Cited by 45 · see citing works
Qiu, M., Ouyang, J., Wei, Y., Zhang, J., Lan, Q., Deng, C., & Zhong, Z. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900500 · Cited by 44 · see citing works
Bauhuber, S., Liebl, R., Tomasetti, L., Rachel, R., Göpferich, A. M., & Breunig, M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.017 · Cited by 42 · see citing works
Cai, W., Lv, W., Yang, F., Yang, H., Zhang, Y., Yang, G., Duan, Y., & Wang, J. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s164760 · Cited by 41 · see citing works
Mumcuoglu, D., Ekiz, M. Ş., Gunay, G., Tekinay, T., Tekinay, A. B., & Guler, M. O. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b01526 · Cited by 41 · see citing works
Intelligent Design of Multifunctional lipid-coated Nanoparticle Platforms for Cancer Therapy
Ramishetti, S., & Huang, L. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.127 · Cited by 39 · see citing works
Self-citationPolycationic nanoparticles synthesized using ARGET ATRP for drug delivery
Forbes, D. C., Creixell, M., Frizzell, H., & Peppas, N. A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.01.007 · Cited by 38 · see citing works
Sun, X., Marque, L. O., Cordner, Z. A., Pruitt, J. L., Bhat, M., Li, P. P., Kannan, G., Ladenheim, E. E., Moran, T. H., Margolis, R. L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu349 · Cited by 37 · see citing works
The role of microRNAs in stemness of cancer stem cells
Rad, S. M. A. H., Bavarsad, M. S., Arefian, E., Jaseb, K., Shahjahani, M., & Saki, N. (2013) · Oncology Reviews · doi:10.4081/oncol.2013.e8 · Cited by 37 · see citing works
Delivery of RNAi therapeutics: work in progress
Miller, A. D. (2013) · Expert Review of Medical Devices · doi:10.1586/17434440.2013.855471 · Cited by 34 · see citing works
Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer
Rad, S. M. A. H., Langroudi, L., Kouhkan, F., Yazdani, L., Koupaee, A. N., Asgharpour, S., Shojaei, Z., Bamdad, T., & Arefian, E. (2015) · Tumor Biology · doi:10.1007/s13277-015-3344-z · Cited by 33 · see citing works
Pan, H., Palekar, R. U., Hou, K. K., Bacon, J., Yan, H., Springer, L. E., Akk, A. M., Yang, L., Miller, M. J., Pham, C. T. N., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s168556 · Cited by 32 · see citing works
Liu, J., Ma, T., Yao, R., Li, L., Zheng, Q., & Wang, M. (2026) · Cell · doi:10.1016/j.cell.2025.12.007 · Cited by 31 · see citing works
Immune responses of therapeutic lipid nanoparticles
Chen, W. C., May, J. P., & Li, S. (2012) · Nanotechnology Reviews · doi:10.1515/ntrev-2012-0040 · Cited by 29 · see citing works
Brief overview of nanoparticulate therapy in cancer
Wakaskar, R. R. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1347175 · Cited by 29 · see citing works
Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment
Chakraborty, K., Tripathi, A., Mishra, S., Mallick, A. M., & Roy, R. S. (2022) · Bioscience Reports · doi:10.1042/bsr20212051 · Cited by 29 · see citing works
Density based visualization for molecular simulation
Rozmanov, D. A., Baoukina, S., & Tieleman, D. P. (2014) · Faraday Discussions · doi:10.1039/c3fd00124e · Cited by 29 · see citing works
Enzyme-Triggered PEGylated pDNA-Nanoparticles for Controlled Release of pDNA in Tumors
Yingyuad, P., Mével, M., Prata, C. A. H., Furegati, S., Kontogiorgis, C. A., Thanou, M., & Miller, A. D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300419g · Cited by 29 · see citing works
Louwies, T., Ligon, C. O., Johnson, A. C., & Meerveld, B. G. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13500 · Cited by 30 · see citing works
Trends in polymeric delivery of nucleic acids to tumors
Yousefi, A., Storm, G., Schiffelers, R. M., & Mastrobattista, E. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.040 · Cited by 28 · see citing works
Green approaches for nanoparticle synthesis: emerging trends
Bhardwaj, P., Singh, B., & Behera, S. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822401-4.00015-5 · Cited by 28 · see citing works
Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis
Khaja, F., Jayawardena, D., Kuzmis, A., & Önyüksel, H. (2016) · Nanomaterials · doi:10.3390/nano6010008 · Cited by 27 · see citing works
Short Interfering RNA (siRNA)-Based Therapeutics for Cartilage Diseases
Zhou, L., Rubin, L. E., Liu, C.-J., & Chen, Y. (2020) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-020-00149-z · Cited by 25 · see citing works
- Authors
- Huang, L., & Liu, Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- ORCID
- Huang, Leaf
- Venue
- Annual Review of Biomedical Engineering
- Publisher
- Annual Reviews
- Published
- 2011-08-15
- Volume
- 13
- Issue
- 1
- Pages
- 507-530
- ISSN
- 1523-9829 (ISSN-L)
- 1545-4274
- OpenAlex
- W2127833150
- Cited by
- 174
- References
- 115
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 5 · 2023: 6 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 9 · 2017: 12 · 2016: 17 · 2015: 8 · 2014: 18 · 2013: 34 · 2012: 21
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA129421, R01CA129835, R01CA129421, R01CA149363, CA149363, CA129835)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- RNA interference, lipid nanoparticles, gene silencing, therapeutic vectors, vector design, vector safety, clinical translation, undruggable targets
- MeSH terms
- Algorithms, Drug Carriers, Genetic Vectors, Humans, Liposomes, Neoplasms, Pharmacokinetics, Polyethylene Glycols, Virus Diseases, Genetic Therapy, Genetic Diseases, Inborn, RNA Interference, RNA, Small Interfering, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review